Seventy isolates of Klebsiellu pneumoniae with extended-spectrum /3-lactamases (ESBLs) were compared. These were isolated from 51 patients on 10 separate wards in one hospital over an 18-month period between 1992 and 1994. Antibiograms were determined and the isolates were typed by pulsed-field gel electrophoresis of their DNA digestion with Xbu I. The isolates were compared to three genotypically different epidemic strains responsible for previous outbreaks at the hospital between 1988 and 1991. Isolates from 84% of the present patients had closely related Xbul patterns, and most (74%) produced an ESBL with an iso-electric point (PI) of 7.0. A similar pattern was found for one of the previous epidemic strains, but it produced an ESBL with a PI of 7.8; isolates with this latter enzyme variant were found only in six of the present patients. The two other previous epidemic strains had ESBLs with a PI of 6.3 and organisms related to them were found in one and two of the present patients, respectively.
Introduction
Klebsiella pneumoniae strains producing extendedspectrum /?-lactamases (ESBLs) can cause endemic and epidemic hospital-acquired infections [ 1-63. They have been responsible for outbreaks, particularly in intensive care units and in chronic care facilities, but have occasionally spread also to medical and surgical wards [7-131. Hospital colonisation by ESBL-producing bacteria can reflect dissemination of a few clones, or the spread of plasmids and resistance genes [13] [14] [15] [16] [17] [18] [19] [20] [21] , facilitated by antibiotic pressure and inadequate infection-control practice [9-10, [22] [23] [24] . Several outbreaks of nosocomial infections caused by ESBL-producing K. pneumoniae occurred in our hospital between 1988 and 199 1. Three genomically different strains were implicated [25] : two strains produced an ESBL with an iso-electric point (PI) of 6.3 and the third had a PI 7.8 ESBL.
ESBL-producing K. pneumoniae were isolated with increasing frequency from 1991 to 1993. By 1993, 40% of the K. pneumoniae isolates from clinical samples were resistant to extended-spectrum cephalosporins. This high incidence could be due to the persistence of one or more of the strains responsible for the previous outbreaks and this possibility was investigated by DNA macrorestriction analysis of isolates and iso-electric focusing of their ESBLs.
Materials and methods

Epidemiological background and bacterial strains
Hospital Beaujon is a University Hospital with c. 700 beds. It has five surgical wards, three of them with intensive care subunits; seven medical wards; two medical intensive care units (ICU) and one surgical ICU. The hospital experienced outbreaks, between 1988 and 1991, caused by three genotypically different ESBL-producing strains of K. pneumoniae [25] . During the following years many patients were still infected or colonised with ESBL-producing K. pneumoniae (Fig.  1) . Thus, K. pneumoniae isolates were obtained from 266 patients in 1993 and 108 (42%) of the patients had ESBL-producing isolates. Between November 1992 and April 1994, 10 different wards had patients colonised with ESBL-producing K. pneumoniae. Almost half (48%) of the patients from whom ESBL producers were obtained were in an intensive care unit, 37% were on surgical wards and 15% on medical wards. Sites of isolation were: urine (26%), stool (20%), drainage (14%), wound (12%), blood (6%), catheter (6%), pulmonary tract (4%) and other sites (12%). After reinforcement of infection-control measures, the incidence of ESBL-producing K. pneurnoniae decreased (Fig. 1) . For the present study, 70 isolates obtained between November 1992 and April 1994 were selected. These were from 51 patients (Table l) , and included the first isolates from 49 patients and all the isolates from two patients (Tables 1 and 2 ).
These isolates were compared to 'epidemic' strains responsible for previous outbreaks between 1988 and 1991 (Table 1) [25] . A control group of five wild-type K. pneurnoniae isolates without ESBLs was also used. These were collected during the same period as the present isolates from patients of five different wards.
All the isolates were identified with the API 20E system (API bioMerieux, Marcy l'etoile, France), and by carbon assimilation tests with ethanolamine and histamine [26] .
Antibiotic susceptibility testing
Susceptibility to antimicrobial agents was tested by the disk difhsion method on Mueller-Hinton Agar (Sanofi Diagnostics Pasteur, Marnes la Coquette, France) interpreted according to the guidelines of the Antibiogram Committee of the French Society for Microbiology [27] . Iso-electric focusing of P-lactamases P-Lactamases were characterised by iso-electric focusing on pH 3.5-9.5 gels (Pharmacia Biotech, Uppsala, Sweden) [30] . P-Lactamase activity was detected by an iodometric method with benzylpenicillin (1 00 mg/L gel) or ceftriaxone (200 mg/L gel) as substrates [l] . P-Lactamases with known PIS (TEM-1, 5.4; TEM-3, 6.3; SHV-3, 7; SHV-1, 7.6; SHV-4, 7.8 and SHV-5, 8.2)
were run in parallel with the extracts.
Genome jingerprinting by pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed as described previously [25] , after digestion of chromosomal DNA with XbaI, which gave a convenient number of fragments. These fragments were separated by a contour-clamped homogeneous electric field (CHEF-DRII system, BioRad, Ivry sur Seine, France) in 0.5 X TBE buffer, pH 8.0, at 12°C and 200 V for 22 h with pulse times of 6-15 s for 7 h and 23-40 s for 15 h. A3  A3  A3  A3  A3  A3  A3   A3  A3  A4  A4  A4  A3  A3  A3  A3  A3  A4  A4  A4  A4 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 5.4, 7.6, 7.8 5.4, 7.6, 7.8 5.4, 7.6, 7.8 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7.6 7.0, 7. 
Results
Antimicrobial susceptibility
All the isolates showed a strong synergy between clavulanic acid and cefotaxime, indicating ESBL production. In addition to resistance to all extendedspectrum cephalosporins and aztreonam, most had multiresistance to pefloxacin, trimethoprim-sulphamethoxazole, tobramycin, netilmicin and amikacin. Isolates with this 'complete' multiresistance were designated phenotype A1 ; those additionally resistant to gentamicin were designated phenotype B1. Some isolates (phenotypes A2 and B2) were also resistant to minocycline, or to minocycline and cefoxitin (phenotypes A3 and B3) or to minocycline, cefoxitin and colistin (phenotype A4). Only one isolate had no associated antibiotic resistance (phenotype C). All the isolates remained susceptible to latamoxef and imipenem.
Comparison of the inhibition zone diameters of cefotaxime, ceftazidime and aztreonam disks indicated three phenotypes [23] . Thus, 55 isolates gave inhibition zones of 18-25 mm to cefotaxime disks compared with 20-27 mm for ceftazidime and 23-30 mm for aztreonam. These were termed the CTXa phenotype. Five isolates gave smaller inhibition zone diameters (1 9-24 mm) around ceftazidime disks than around cefotaxime (24-25 rnm) and aztreonam (25-30mm) disks and were termed the CTXb phenotype. Ten isolates gave smaller inhibition zone diameters (7-1 1 mm) around ceftazidime and aztreonam disks than around cefotaxime disks (19-24 m) and were termed the CAZ resistance phenotype. MICs of cefotaxime, ceftazidime and aztreonam for isolates of each phenotype and the five ESBL-negative control isolates are shown in Table 3 and broadly supported the inhibition zone data.
Iso-electric focusing
Iodometric development with ceftriaxone as substrate revealed at least one reactive band in each isolate. Fifty-four isolates had a ceftriaxone-hydrolysing band at PI 7.0, 10 had a band at PI 7.8 and three had a band at PI 6.3. Two bands were detected in three isolates: one isolate had bands at PI 7.0 and 8.2 and two had bands at PI 6.3 and 7.0. With penicillin as substrate, all isolates but one had an additional PI 7.6 band, 
PFGE of macrorestriction fragments
AEter digestion with XbaI, K. pneumoniae D N A gave 11-22 fragments of 30-600 kb (Figs. 2 and 3) . Six 'major patterns' were found among the ESBL-producing isolates. When single band differences were taken to distinguish XbaI patterns a total of 31 profiles was found and another five separate patterns were found amongst the five ESBL-negative K. pneumoniae isolates. All the major patterns were distinct, sharing <38% similarity (Fig. 4) . The first isolates of 42 patients were all of major pattern 1 (Table 1 ) and, within this group, variant patterns differed by 1 -10 bands, but had similarity coefficients >80%. Two patients had isolates of major pattern 8, which was subdivided into patterns 8b and 8c, differing by four bands and retaining a similarity coefficient of 86%. Four patients had identical isolates of major pattern 9b. The isolates from the remaining three patients were of distinct major patterns designated 2, 10 and 11. Consecutive isolates from patients 29 and 47 were all of major pattern 1 (Table 2 and Fig. 3) . Isolates of major pattern 1 were widespread throughout the ho spi t a1 .
Relationships between strain type and antibiogram
All the isolates that produced only the PI 7.0 ESBL had the CTXa resistance phenotype, suggesting that they produced a SHV-3 p-lactamase [23, 28, Among 42 patients with isolates of major pattern 1, 37 had isolates with a PI 7.0 ESBL (Tables 1, 2 and 4). Two of these also produced a PI 6.3 ESBL and one had a PI 8.2 ESBL. Five other patients had isolates of major pattern 1 but with a PI 7.8 ESBL. An ESBL with a PI of 7.0 was also found in one isolate of major pattern 8 and two isolates of major pattern 9 (Tables 1 and 3 ). The single isolates of major patterns 10 and 11 produced PI 7.8 ESBLs. An ESBL with a PI of 6.3 was found in three isolates, one of major pattern 8 and two of major pattern 9 (Tables 1 and 4) . 
Consecutive isolates from patients 29 and 47
Isolates from patient 29 were obtained over 3 weeks from drainage after pulmonary surgery. This patient also had a digestive tract colonisation. Although the isolates were obtained over a short period, four variants of major pattern 1 were found, differing by two to three bands. An ESBL with a PI of 7.0 was found in all these isolates (Table 2) .
Patient 47, who underwent a lung transplantation, suffered several episodes of infection with ESBLproducing K. pneumoniae isolates during his 1 0-month stay in the medical intensive care unit. He also had a digestive tract colonisation and this remained even after oral decontamination with colistin. ESBL-producing K. pneumoniae isolates resistant to colistin (phenotype A4) were subsequently isolated (Table 2 ). Among the isolates tested, three produced a PI 7.8 ESBL and 11 had a PI 7.0 ESBL. All were of the major pattern 1, but seven variants were found, differing by one to four bands. The similarity coefficients between the variants were >90%.
Relationships between the present isolates and previous epidemic strains
Most (84%) patients had isolates of major pattern 1, similar to the epidemic serotype K25 strain responsible for outbreaks I and IV in 1988 and 1991 (Table 1) [25] . A representative strain from outbreak I (pattern It) had an XbaI pattern very similar to that from patient 38 (pattern lu), whereas the profile of a strain from outbreak IV (pattern lw) was similar to that of the isolate from patient 18 (pattern lv) (Table 1 and Fig.  4) . However, these strains from epidemics I and IV produced an ESBL with a PI of 7.8, whereas most (74%) of the present pattern 1 isolates had a PI 7.0 ESBL. Only eight major pattern 1 isolates with a PI 7.8 ESBL were obtained. Five of these were from patients in the vascular and thoracic surgery ward, where the outbreak caused by epidemic strain IV occurred in 1991. The other three isolates were among the consecutive isolates of patient 47, who was hospitalised in the medical intensive care unit but had undergone pulmonary surgery in the vascular and thoracic surgery ward. These three isolates also produced a PI 5.4 Plactamase.
All the isolates of major pattern 1 were urease-and sucrose-negative in the API 20E system, as was the strain responsible for outbreaks I and IV;
Outbreak 11, which occurred in the surgical intensive care unit in 1988, was due to an epidemic strain of major pattern 9, which produced a PI 6.3 ESBL and a PI 5.4 P-lactamase. Similar isolates were obtained from two patients in the medical intensive care unit in the present study. Isolates of major pattern 9 were also isolated from two patients in the digestive surgery ward, but these produced a PI 7.0 ESBL.
Another outbreak due to an ESBL-producing K. pneumoniae strain (epidemic strain 111) occurred in the surgical intensive care unit in 1990-1991. This strain was of major pattern 8 and produced a PI 6.3 ESBL together with a PI 5.4 P-lactamase. Only one similar isolate was found in the present study, from a patient on the orthopaedic surgery ward. This isolate was resistant to gentamicin, but its resistance phenotype differed from epidemic strain 111, in that it was sensitive to minocycline and cefoxitin. Another isolate of major pattern 8 was found in a patient on the vascular and thoracic surgery ward, but had a PI 7.0 ESBL.
Discussion
Transferable resistance to broad-spectrum cephalosporins has been found worldwide [23, 31, 321 and is mostly mediated by ESBLs. Isolate with these enzymes were originally recovered from patients hospitalised in ICUs, and this pattern has remained in our hospital, where most ESBL-producing K. pneumoniae were from patients on surgical wards and ICUs. They were mainly isolated from urines and wounds, whereas the incidence of bacteraemia was lower than in other studies [I, 321.
Our hospital experienced four outbreaks due to ESBLproducing K. pneumoniae between 1988 and 1991 [25] . Two outbreaks in 1988 and 1990 were caused by two different TEM-3 P-lactamase-producing strains; two further outbreaks in 1988 and 1991 were caused by a different SHV-4 P-lactamase-producing strain. These enzymes, and also SHV-3 P-lactamase, have been found in outbreak strains of K. pneumoniae elsewhere in France [l, 3, 4, 7-9, 281. Since the last outbreak and until the end of 1993, ESBL-producing K. pneumoniae isolates have been found with increasing frequency at our hospital and were isolated on 10 wards during the 18 months of the present study.
Identification of the mode of transmission is necessary to take efficient control measures. In particular, it is important to know whether the increasing number of isolates was the result of the spread of the former epidemic strains or the introduction of different strains by patients who were colonised on admission. PFGE of chromosomal DNA was used to differentiate these possibilities. This method allows estimation of interstrain relatedness, which is useful for tracing the evolution of epidemic strains over extended periods [14, 331. We considered that XbaI profiles differing by up to 10 fragments were likely to represent genotypic variants of the same epidemic clone. This threshold corresponds to c. 80% similarity. Based on this definition, PFGE showed that a major pattern 1 strain producing a PI 7.0 P-lactamase (putatively SHV-3) had disseminated through most of the wards in our hospital and persisted for at least 18 months. This supports previous reports of the spread of single clones of K. pneumoniae among patients on different wards over protracted periods [l-31. This pattern 1 strain was also responsible for the two outbreaks in 1988 and 1991, but then produced an ESBL with a PI of 7.8 (putatively SHV-4). Isolates with the PI 7.8 enzyme were encountered infrequently during the 18 months of the present study, and were mostly found on the ward where the outbreak occurred in 1991.
One patient in the present study was colonised for at least 10 months with isolates showing minor variations of pattern 1. Some of the isolates produced a PI 7.0 (putative SHV-3) P-lactamase whereas others had a PI 7.8 (SHV-4) P-lactamase. showed that EcoRI restriction profiles of plasmids encoding the P-lactamases were similar [ 141. In the present study, most of the XbaI pattern 1 isolates producing the PI 7.0 (putative SHV-3) p-lactamase had characteristics similar to those of the K. pneumoniae strains producing SHV-4 P-lactamase responsible for outbreaks in other French hospitals; they were resistant to aminoglycosides except gentamicin and had negative urease and sucrose reactions. The dissemination of both SHV-3 and SHV-4 P-lactamases in French hospitals could be due to the propagation of a single clone. This could be verified by comparing SHV-3-and SHV-4-producing isolates responsible for infections in various French hospitals by PFGE macrorestriction DNA analysis. However, a few sporadic cases of infection due to SHV-3-producing K. pneumoniae isolates of unrelated genome type were observed during the present study, showing that SHV-3 can also occur in diverse strains.
The epidemiology of ESBL-producing K. pneumoniae is complex and involves the spread of self-transferable plasmids and the transposition of resistance genes among different plasmids as well as clonal strain spread. For instance, TEM-3 p-lactamase became widespread in France in the late 1980s, mainly due to the dissemination of a plasmid carrying its gene Although strains producing SHV-5 p-lactamase have recently been responsible for nosocomial infections and outbreaks in several countries [2, 18, 381, an ESBL with a PI of 8.2 (putative SHV-5) was found in only one of the isolates studied. This isolate also produced a PI 7.0 (SHV-3) ESBL. Two other isolates produced two ESBLs simultaneously, having PI 6.3 and 7.0 types. Strains with two ESBLs are infrequent, but have been described several times [39-411. Intestinal colonisation may provide a reservoir for nosocomial klebsiella infections [42] , and gut colonisation is frequent among patients in intensive care units [7, 24, 251 . In addition to strict hygienic practices, intestinal decontamination with non-absorbed antibiotics was recommended for controlling this problem [43] . However, repeated oral ingestion of colistin did not eradicate ESBL-producing K. pneumoniae colonisation from patient no. 47. Rather, this patient remained colonised with the same K. pneumoniae strain for 10 months, with several episodes of infection. Isolates resistant to colistin were cultured.
DNA macrorestriction analysis by PFGE, combined with 0-lactamase characterisation, is a good tool for comparing strains isolated several years apart. It showed that the frequent isolation of ESBL-producing K. pneumoniae in our hospital was due to the spread and persistence of an organism related to a former epidemic strain, but now putatively producing SHV-3 rather than SHV-4 ESBL.
